Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.

Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, Arastu-Kapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H, Walker GD, Reynolds EC, Faull RLM, Curtis MA, Dragunow M, Potempa J.

Sci Adv. 2019 Jan 23;5(1):eaau3333. doi: 10.1126/sciadv.aau3333. eCollection 2019 Jan.

2.

Hypoxia-induced endothelial cell responses - possible roles during periodontal disease.

Mendes RT, Nguyen D, Stephens D, Pamuk F, Fernandes D, Hasturk H, Van Dyke TE, Kantarci A.

Clin Exp Dent Res. 2018 Dec 14;4(6):241-248. doi: 10.1002/cre2.135. eCollection 2018 Dec.

3.

Endogenous acid ceramidase protects epithelial cells from Porphyromonas gingivalis-induced inflammation in vitro.

Azuma MM, Balani P, Boisvert H, Gil M, Egashira K, Yamaguchi T, Hasturk H, Duncan M, Kawai T, Movila A.

Biochem Biophys Res Commun. 2018 Jan 22;495(4):2383-2389. doi: 10.1016/j.bbrc.2017.12.137. Epub 2017 Dec 24.

4.

Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.

Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T.

Curr Atheroscler Rep. 2017 Nov 6;19(12):57. doi: 10.1007/s11883-017-0696-4. Review.

PMID:
29110146
5.

Spontaneous PMN apoptosis in type 2 diabetes and the impact of periodontitis.

Manosudprasit A, Kantarci A, Hasturk H, Stephens D, Van Dyke TE.

J Leukoc Biol. 2017 Dec;102(6):1431-1440. doi: 10.1189/jlb.4A0416-209RR. Epub 2017 Oct 11.

PMID:
29021368
6.

Microbes and host response: A relationship between health and disease.

Kantarci A, Hasturk H.

Oral Dis. 2018 Nov;24(8):1385-1387. doi: 10.1111/odi.12731. Epub 2017 Sep 14. No abstract available.

PMID:
28799244
7.

Collaborative Cross Mouse Population for Studying Alveolar Bone Changes and Impaired Glucose Tolerance Comorbidity After High-Fat Diet Consumption.

Nashef A, Abu-Toamih Atamni HJ, Buchnik Y, Hasturk H, Kantarci A, Stephens D, Wiess EI, Houri-Haddad Y, Iraqi FA.

J Periodontol. 2017 Sep;88(9):e150-e158. doi: 10.1902/jop.2017.170075. Epub 2017 May 19.

PMID:
28523955
8.

Impact of Docosahexaenoic Acid Therapy on Subgingival Plaque Microbiota.

Naqvi AZ, Mu L, Hasturk H, Van Dyke TE, Mukamal KJ, Goodson JM.

J Periodontol. 2017 Sep;88(9):887-895. doi: 10.1902/jop.2017.160398. Epub 2017 May 18.

PMID:
28517974
9.

Dental plaque microbial profiles of children from Khartoum, Sudan, with congenital heart defects.

Mohamed Ali H, Berggreen E, Nguyen D, Wahab Ali R, Van Dyke TE, Hasturk H, Mustafa M.

J Oral Microbiol. 2017 Jan 27;9(1):1281556. doi: 10.1080/20002297.2017.1281556. eCollection 2017.

10.

The salivary microbiome is altered in the presence of a high salivary glucose concentration.

Goodson JM, Hartman ML, Shi P, Hasturk H, Yaskell T, Vargas J, Song X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K.

PLoS One. 2017 Mar 1;12(3):e0170437. doi: 10.1371/journal.pone.0170437. eCollection 2017.

11.

Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function.

Kurgan Ş, Kansal S, Nguyen D, Stephens D, Koroneos Y, Hasturk H, Van Dyke TE, Kantarci A.

J Periodontol. 2017 Apr;88(4):380-389. doi: 10.1902/jop.2016.160212. Epub 2016 Oct 20.

PMID:
27762731
12.
13.

Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents.

Hartman ML, Goodson JM, Shi P, Vargas J, Yaskell T, Stephens D, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F.

J Obes. 2016;2016:6860240. doi: 10.1155/2016/6860240. Epub 2016 Mar 16.

14.

Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes.

Wang CW, Colas RA, Dalli J, Arnardottir HH, Nguyen D, Hasturk H, Chiang N, Van Dyke TE, Serhan CN.

Infect Immun. 2015 Dec 14;84(3):658-65. doi: 10.1128/IAI.01131-15.

15.

Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers.

Shi P, Goodson JM, Hartman ML, Hasturk H, Yaskell T, Vargas J, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F.

PLoS One. 2015 Sep 29;10(9):e0138979. doi: 10.1371/journal.pone.0138979. eCollection 2015.

16.

Activation and resolution of periodontal inflammation and its systemic impact.

Hasturk H, Kantarci A.

Periodontol 2000. 2015 Oct;69(1):255-73. doi: 10.1111/prd.12105. Review.

17.

LXA4 actions direct fibroblast function and wound closure.

Herrera BS, Kantarci A, Zarrough A, Hasturk H, Leung KP, Van Dyke TE.

Biochem Biophys Res Commun. 2015 Sep 4;464(4):1072-1077. doi: 10.1016/j.bbrc.2015.07.076. Epub 2015 Jul 17.

18.

Systemic vitamin D supplementation and local bone formation after maxillary sinus augmentation - a randomized, double-blind, placebo-controlled clinical investigation.

Schulze-Späte U, Dietrich T, Wu C, Wang K, Hasturk H, Dibart S.

Clin Oral Implants Res. 2016 Jun;27(6):701-6. doi: 10.1111/clr.12641. Epub 2015 Jul 14.

PMID:
26178580
19.

Animal models for periodontal regeneration and peri-implant responses.

Kantarci A, Hasturk H, Van Dyke TE.

Periodontol 2000. 2015 Jun;68(1):66-82. doi: 10.1111/prd.12052. Review.

20.

Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.

Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE.

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1123-33. doi: 10.1161/ATVBAHA.115.305324. Epub 2015 Mar 19.

21.

The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract.

Macovei L, McCafferty J, Chen T, Teles F, Hasturk H, Paster BJ, Campos-Neto A.

J Oral Microbiol. 2015 Feb 13;7:26094. doi: 10.3402/jom.v7.26094. eCollection 2015.

22.

IPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis.

Ayilavarapu S, Kantarci A, Hasturk H, Van Dyke TE.

J Int Acad Periodontol. 2014 Oct;16(4):121-6.

23.

Subgingival microbial profiles of Sudanese patients with aggressive periodontitis.

Elabdeen HR, Mustafa M, Hasturk H, Klepac-Ceraj V, Ali RW, Paster BJ, Van Dyke T, Bolstad AI.

J Periodontal Res. 2015 Oct;50(5):674-82. doi: 10.1111/jre.12250. Epub 2014 Dec 9.

24.

Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes.

Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE.

Infect Immun. 2015 Feb;83(2):792-801. doi: 10.1128/IAI.02444-14. Epub 2014 Dec 8.

25.

Proresolving nanomedicines activate bone regeneration in periodontitis.

Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, Serhan CN.

J Dent Res. 2015 Jan;94(1):148-56. doi: 10.1177/0022034514557331. Epub 2014 Nov 11.

26.

Docosahexaenoic Acid and Periodontitis in Adults: A Randomized Controlled Trial.

Naqvi AZ, Hasturk H, Mu L, Phillips RS, Davis RB, Halem S, Campos H, Goodson JM, Van Dyke TE, Mukamal KJ.

J Dent Res. 2014 Aug;93(8):767-73. doi: 10.1177/0022034514541125. Epub 2014 Jun 26.

27.

Metabolic disease risk in children by salivary biomarker analysis.

Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F.

PLoS One. 2014 Jun 10;9(6):e98799. doi: 10.1371/journal.pone.0098799. eCollection 2014.

28.

Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury.

Martin CR, Zaman MM, Gilkey C, Salguero MV, Hasturk H, Kantarci A, Van Dyke TE, Freedman SD.

PLoS One. 2014 Jun 3;9(6):e98773. doi: 10.1371/journal.pone.0098773. eCollection 2014.

29.

The use of light/chemically hardened polymethylmethacrylate, polyhydroxylethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants and extraction sockets in minipigs: Part II: histologic and micro-CT evaluations.

Hasturk H, Kantarci A, Ghattas M, Dangaria SJ, Abdallah R, Morgan EF, Diekwisch TG, Ashman A, Van Dyke T.

J Periodontol. 2014 Sep;85(9):1230-9. doi: 10.1902/jop.2014.120424. Epub 2014 Feb 6.

30.

Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model.

Zenobia C, Hasturk H, Nguyen D, Van Dyke TE, Kantarci A, Darveau RP.

Infect Immun. 2014 Feb;82(2):650-9. doi: 10.1128/IAI.01136-13. Epub 2013 Nov 25.

31.

Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Cekici A, Kantarci A, Hasturk H, Van Dyke TE.

Periodontol 2000. 2014 Feb;64(1):57-80. doi: 10.1111/prd.12002. Review.

33.

Alternative splicing generates a diacylglycerol kinase α transcript that acts as a dominant-negative modulator of superoxide production in localized aggressive periodontitis.

Batista EL Jr, Kantarci AI, Hasturk H, Van Dyke TE.

J Periodontol. 2014 Jul;85(7):934-43. doi: 10.1902/jop.2013.130468. Epub 2013 Oct 30.

34.

Obesity and dental decay: inference on the role of dietary sugar.

Goodson JM, Tavares M, Wang X, Niederman R, Cugini M, Hasturk H, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K.

PLoS One. 2013 Oct 10;8(10):e74461. doi: 10.1371/journal.pone.0074461. eCollection 2013.

35.

Comparison of the impact of scaler material composition on polished titanium implant abutment surfaces.

Hasturk H, Nguyen DH, Sherzai H, Song X, Soukos N, Bidlack FB, Van Dyke TE.

J Dent Hyg. 2013 Aug;87(4):200-11.

PMID:
23986413
36.

Resolvin D1 protects periodontal ligament.

Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan C, Kantarci A, Van Dyke TE.

Am J Physiol Cell Physiol. 2013 Sep 15;305(6):C673-9. doi: 10.1152/ajpcell.00242.2012. Epub 2013 Jul 17.

37.

Effect of periodontal therapy on the subgingival microbiota over a 2-year monitoring period. I. Overall effect and kinetics of change.

Socransky SS, Haffajee AD, Teles R, Wennstrom JL, Lindhe J, Bogren A, Hasturk H, van Dyke T, Wang X, Goodson JM.

J Clin Periodontol. 2013 Aug;40(8):771-80. doi: 10.1111/jcpe.12117. Epub 2013 May 27.

38.

Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity?

Hartman ML, Groppo F, Ohnishi M, Goodson JM, Hasturk H, Tavares M, Yaskell T, Floros C, Behbehani K, Razzaque MS.

Contrib Nephrol. 2013;180:138-48. doi: 10.1159/000346793. Epub 2013 May 3.

39.

Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.

Berker E, Kantarci A, Hasturk H, Van Dyke TE.

J Periodontol. 2013 Sep;84(9):1337-45. doi: 10.1902/jop.2012.120422. Epub 2012 Nov 23.

40.

A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.

Yao M, Hasturk H, Kantarci A, Gu G, Garcia-Lavin S, Fabbi M, Park N, Hayashi H, Attala K, French MA, Driver VR.

Int Wound J. 2014 Dec;11(6):586-93. doi: 10.1111/iwj.12005. Epub 2012 Nov 19.

PMID:
23163982
41.

Deep sequencing of the oral microbiome reveals signatures of periodontal disease.

Liu B, Faller LL, Klitgord N, Mazumdar V, Ghodsi M, Sommer DD, Gibbons TR, Treangen TJ, Chang YC, Li S, Stine OC, Hasturk H, Kasif S, Segrè D, Pop M, Amar S.

PLoS One. 2012;7(6):e37919. doi: 10.1371/journal.pone.0037919. Epub 2012 Jun 4.

42.

Oral inflammatory diseases and systemic inflammation: role of the macrophage.

Hasturk H, Kantarci A, Van Dyke TE.

Front Immunol. 2012 May 16;3:118. doi: 10.3389/fimmu.2012.00118. eCollection 2012.

43.

Analysis of bone formation after sinus augmentation using β-tricalcium phosphate.

Schulze-Späte U, Dietrich T, Kayal RA, Hasturk H, Dobeck J, Skobe Z, Dibart S.

Compend Contin Educ Dent. 2012 May;33(5):364-8.

PMID:
22616219
44.

Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites.

Goodson JM, Haffajee AD, Socransky SS, Kent R, Teles R, Hasturk H, Bogren A, Van Dyke T, Wennstrom J, Lindhe J.

J Clin Periodontol. 2012 Jun;39(6):526-36. doi: 10.1111/j.1600-051X.2012.01870.x. Epub 2012 Apr 18.

PMID:
22512461
45.

Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray.

Colombo AP, Bennet S, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst FE, Paster BJ.

J Periodontol. 2012 Oct;83(10):1279-87. Epub 2012 Feb 10.

46.

Paradigm shift in the pharmacological management of periodontal diseases.

Hasturk H, Kantarci A, Van Dyke TE.

Front Oral Biol. 2012;15:160-76. doi: 10.1159/000329678. Epub 2011 Nov 11. Review.

47.

Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1.

Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, Van Dyke TE.

PLoS One. 2011;6(9):e24422. doi: 10.1371/journal.pone.0024422. Epub 2011 Sep 14.

48.

The use of light/chemically hardened polymethylmethacrylate, polyhydroxyethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants in minipigs: part I: immediate stability and function.

Hasturk H, Kantarci A, Ghattas M, Schmidt M, Giordano RA, Ashman A, Diekwisch TG, Van Dyke T.

J Periodontol. 2011 Sep;82(9):1339-52. doi: 10.1902/jop.2011.100617. Epub 2011 Feb 22.

49.

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.

Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, Nikolajczyk BS.

J Immunol. 2011 Jan 15;186(2):1162-72. doi: 10.4049/jimmunol.1002615. Epub 2010 Dec 17.

50.

Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells.

Liang Y, Hasturk H, Elliot J, Noronha A, Liu X, Wetzler LM, Massari P, Kantarci A, Winter HS, Farraye FA, Ganley-Leal LM.

Clin Immunol. 2011 Jan;138(1):33-40. doi: 10.1016/j.clim.2010.09.003. Epub 2010 Oct 14.

PMID:
20947433

Supplemental Content

Loading ...
Support Center